Skip to NavigationSkip to content

News

The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports emerged of treatment-related safety...
A US jury has awarded a former Genentech employee nearly $250,000 after the black worker was fired from the firm after filing a racial-...
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO.
Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the...
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, according to research...
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, detailing the efficacy of the product in preventing...
Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is otherwise recognised by...
Doctors have successfully treated porphyria using an innovative ‘gene-silencing’ drug.
Janssen’s Balversa (erdafitinib) has become the first FDA-approved fibroblast growth factor receptor (FGFR) kinase inhibitor after the US agency...
Colorado-based pharma firm Clovis Oncology has said in a filing to the US Securities and Exchange Commission that it is discontinuing the phase 2...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches